002019.SZ
亿帆医药
SZSE · Healthcare · C 制造业 · CN
CNY 9.84
−2.86%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
16.6x
Market Cap
CNY 11.97B
MomentumView details →
1D Return
−2.86%
YTD Return
−19.31%
RSI (14)
40.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
16.6x
Market Cap
CNY 11.97B
RSI (14)
40.3
MomentumView details →
1D Return
−2.86%
YTD Return
−19.31%
Similar companies
Latest newsMore news →
Yifan Pharmaceutical established a new medical technology company, Hefei Huansheng Medical Technology Co., Ltd., in Hefei, China, with Zhang Xin as legal representative, indirectly wholly owned by Yifan Pharmaceutical.16d agoYifan Pharmaceutical provided a maximum 2 billion yuan joint liability guarantee to its wholly-owned subsidiary Hefei Yifan by signing an agreement with China Merchants Bank Hefei Branch on July 21, 2026.45d ago